(Q48702727)

14 February 2018

title

Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze (English)

1 reference

14 February 2018

1 reference

Wall PM

1

1 reference

14 February 2018

Messier C

series ordinal

2

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

14 February 2018

Behavioural Brain Research

published in

1 reference

14 February 2018

volume

114

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

199-212

1 reference

14 February 2018

On the Equivalence of Factors and Components

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

The characterization and modelling of antipredator defensive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

The Maslach Burnout Inventory: Validating Factorial Structure and Invariance Across Intermediate, Secondary, and University Educators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Testing for the Factorial Validity, Replication, and Invariance of a Measuring Instrument: A Paradigmatic Application Based on the Maslach Burnout Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Use of the elevated plus maze in the search for novel anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Effects of weekly or daily exposure to the elevated plus-maze in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

The influence of open arm ledges and maze experience in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Structure of the mouse behaviour on the elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

The interplay of learning and anxiety in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Common Factor Analysis versus Component Analysis: Some Well and Little Known Facts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Relation of sample size to the stability of component patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Specification searches in covariance structure modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Some Factors Affecting the Success of Specification Searches in Covariance Structure Modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Differences in fear motivated behaviors among inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

Concurrent modulation of anxiety and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900229-1

7 January 2021

10.1016/S0166-4328(00)00229-1

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018